An honest answer about her sons would mean talking about all the things Duchenne MD has taken from them, writes columnist.

A Phase 3 clinical trial testing SGT-003, a gene therapy candidate for Duchenne muscular dystrophy (DMD), will start dosing ...

A clinical trial testing Duchenne gene-editing therapy candidate PBGENE-DMD will soon launch in the U.S., having won clearance from the FDA.

After realizing that his friends were eager to learn about his MD, columnist Patrick Moeschen became more passionate about ...

Dangerous snow and ice, along with FSHD symptoms, made it impossible for columnist Robin Stemple to leave his home for two weeks.

When faced with a bad moment or adverse event, columnist Patrick Moeschen says it helps to remember the rule of 10.

Columnist Betty Vertin is grateful she's been able to manage cold and flu season at home for her three sons with DMD, and her whole family.

Aging with muscular dystrophy (MD) can involve gradual changes in strength, mobility, and daily functioning. Understanding MD progression can help you and your family anticipate these changes and plan ...

The FDA has granted fast track designation to Dyscorban, Cumberland's therapy candidate for heart problems in people with Duchenne MD.

A research collaboration led by the Muscular Dystrophy Association (MDA) aims to create a molecular map of human muscle regeneration, a project that could accelerate the development of muscle ...

Columnist Shalom Lim experienced a range of emotions while watching other actors perform a play he wrote about muscular dystrophy.